Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02256488
What this trial is testing

Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects

Who this might be right for
Prophylaxis: Influenza
Novartis Vaccines 1,561
Not applicableUnknownNCT04297462
What this trial is testing

Different Regimens in Influenza Postexposure Chemoprophylaxis in Children

Who this might be right for
InfluenzaExposurePrevention
Centre of Postgraduate Medical Education 50
Large-scale testing (Phase 3)Study completedNCT01961947
What this trial is testing

Study of ASP7374, Cell-culture-derived Influenza Vaccine

Who this might be right for
InfluenzaVaccine
UMN Pharma Inc. 900
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Not applicableNot Yet RecruitingNCT07516977
What this trial is testing

Noseguard for Prevention of Respiratory Infections in Real-World Use

Who this might be right for
Respiratory Infection VirusCOVID-19Influenza
Daewoong Pharmaceutical Co. LTD. 2,000
Not applicableStudy completedNCT04611061
What this trial is testing

Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

Who this might be right for
Acute Upper Respiratory Tract InfectionInfluenzaRespiratory Viral Infection
Nearmedic Plus LLC 204
Post-approval studies (Phase 4)Study completedNCT03160118
What this trial is testing

Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults

Who this might be right for
Prevention of Influenza
University Hospital, Ghent 20
Post-approval studies (Phase 4)Study completedNCT01863849
What this trial is testing

Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection

Who this might be right for
Influenza Prophylaxis
Fluart Innovative Vaccine Ltd, Hungary 120
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Testing effectiveness (Phase 2)Ended earlyNCT05567783
What this trial is testing

Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Who this might be right for
Influenza A
Vir Biotechnology, Inc. 2,977
Not applicableStudy completedNCT02964871
What this trial is testing

Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities

Who this might be right for
Influenza, HumanPneumonia
University of Wisconsin, Madison 20
Post-approval studies (Phase 4)Study completedNCT00304434
What this trial is testing

Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

Who this might be right for
Influenza
US Department of Veterans Affairs 48
Testing effectiveness (Phase 2)Study completedNCT05696067
What this trial is testing

Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers

Who this might be right for
COVID-19
Tatyana Zubkova 200
Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT00734734
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009

Who this might be right for
Interpandemic Influenza
Novartis Vaccines 64
Testing effectiveness (Phase 2)Study completedNCT00370864
What this trial is testing

Study of a Pandemic Influenza Vaccine in Children

Who this might be right for
Influenza
Seqirus 220
Large-scale testing (Phase 3)Study completedNCT05091307
What this trial is testing

Ad26.COV2.S and Influenza Vaccines in Healthy Adults

Who this might be right for
COVID-19 Prevention
Janssen Vaccines & Prevention B.V. 861
Early research (Phase 1)Study completedNCT00110279
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00488046
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 16
Early research (Phase 1)Looking for participantsNCT06863142
What this trial is testing

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionSeasonal Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 45
Next Page